End Tb Strategy | List of Frontiers open access articles

Review

Published on 28 Sep 2021

Application of Computational Methods in Understanding Mutations in Mycobacterium tuberculosis Drug Resistance

in Biological Modeling and Simulation

Grace Mugumbate
Brilliant Nyathi
Albert Zindoga
Gadzikano Munyuki

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2021.643849

6,835 views
15 citations

Original Research

Published on 29 Jun 2022

Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?

in Drugs Outcomes Research and Policies

Mariana do Rosário Souza
Wandklebson Silva da Paz
Vinícius Barbosa dos Santos Sales
Gleidson Felipe Hilario de Jesus
Débora dos Santos Tavares
Shirley V. M. Almeida Lima
Álvaro Francisco Lopes Sousa
Enaldo Vieira de Melo
Rodrigo Feliciano do Carmo
Carlos Dornels Freire de Souza

Frontiers in Pharmacology

doi 10.3389/fphar.2022.891711

7,204 views
38 citations

Correction

Published on 06 Sep 2022

Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?

in Drugs Outcomes Research and Policies

Mariana do Rosário Souza
Wandklebson Silva da Paz
Vinícius Barbosa dos Santos Sales
Gleidson Felipe Hilario de Jesus
Débora dos Santos Tavares
Shirley V. M. Almeida Lima
Álvaro Francisco Lopes Sousa
Enaldo Vieira de Melo
Rodrigo Feliciano do Carmo
Carlos Dornels Freire de Souza

Frontiers in Pharmacology

doi 10.3389/fphar.2022.999301

1,696 views
2 citations

Review

Published on 24 Mar 2022

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field

in Antimicrobials, Resistance and Chemotherapy

Navisha Dookie
Azraa Khan
Nesri Padayatchi
Kogieleum Naidoo

Frontiers in Microbiology

doi 10.3389/fmicb.2022.775030

20,760 views
58 citations

Mini Review

Published on 25 Jun 2021

Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis

in Microbial Immunology

Pavithra Sampath
Krisna Moorthi Periyasamy
Uma Devi Ranganathan
Ramalingam Bethunaickan

Frontiers in Immunology

doi 10.3389/fimmu.2021.667206

12,543 views
42 citations

Original Research

Published on 20 Jun 2025

Trends and impact of government prevention policies on pulmonary tuberculosis notification and mortality in Ningbo, China (2004–2021)

in Epidemiology of Tuberculosis

Tianfeng He
Lin Lin
Xujun Qian
Weitao Yao
Guoxing Li
Jing Huang

Frontiers in Tuberculosis

doi 10.3389/ftubr.2025.1615486

1,221 views

Review

Published on 07 Dec 2021

Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies

in Microbiome in Health and Disease

Dramane Diallo
Anou M. Somboro
Seydou Diabate
Bacar Baya
Amadou Kone
Yeya S. Sarro
Bourahima Kone
Bassirou Diarra
Souleymane Diallo
Mahamadou Diakite

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2021.673100

13,706 views
35 citations

Original Research

Published on 17 Mar 2021

Relapse or Re-Infection, the Situation of Recurrent Tuberculosis in Eastern China

in Bacteria and Host

Yan Shao
Honghuan Song
Guoli Li
Yan Li
Yishu Li
Limei Zhu
Wei Lu
Cheng Chen

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2021.638990

23,699 views
23 citations

Clinical Trial

Published on 15 Dec 2021

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis

in Alloimmunity and Transplantation

Juan Liang
Liang Fu
Man Li
Yuyuan Chen
Yi Wang
Yi Lin
Hailin Zhang
Yan Xu
Linxiu Qin
Juncai Liu

Frontiers in Immunology

doi 10.3389/fimmu.2021.756495

7,583 views
23 citations

Original Research

Published on 29 Oct 2025

Effect of population aging on pulmonary tuberculosis burden in Zhejiang Province, China: a population-based study

in Aging and Public Health

Yuxiao Ling
Wei Wang
Songhua Chen
Yu Zhang
Qian Wu
Xinyi Chen
Kui Liu
Ke Yang
Dan Luo
Yang Li

Frontiers in Public Health

doi 10.3389/fpubh.2025.1647139

1,177 views
1 citation

Study Protocol

Published on 15 Oct 2025

Consolidation of a genomic epidemiological surveillance network for tuberculosis (REVIGET) in northern and northeastern Brazil: a study protocol

in Infectious Diseases: Epidemiology and Prevention

Emilyn Costa Conceição
Karla Valéria Batista Lima
Cristiane Cunha Frota
Theolis Costa Barbosa Bessa
Adriana Ayden Ferreira
Abhinav Sharma
Davi Josué Marcon
Layana Rufino Ribeiro
Alex Brito Souza
Danna Karen Corrêa dos Santos

Frontiers in Public Health

doi 10.3389/fpubh.2025.1668926

2,045 views

Original Research

Accepted on 05 Feb 2026

Evaluation of the performance of promising host transcriptional biosignatures in predicting TB progression during a 1-year prospective cohort study in Indian household contacts

in Diagnosis of Tuberculosis

Synne Jenum
Steffen Hadasch
Dhanasekaran Sivakumaran
Christina Skår Saghaug
Jonas Høgberg
Kasama Chusang Larsen
Sumithra Selvam
Helene Larsen
Christian Ritz
Harleen Grewal

Frontiers in Tuberculosis

224 views

Original Research

Published on 16 Jan 2023

Introduction of short course treatment for latent tuberculosis infection at a primary care facility for refugees in Winnipeg, Canada: A mixed methods evaluation

in Infectious Diseases: Epidemiology and Prevention

Claudyne Chevrier
Mariana Herrera Diaz
Zulma Vanessa Rueda
Shivoan Balakumar
Margaret Haworth-Brockman
Diana Marcela Marin
Afsaneh Oliver
Pierre Plourde
Yoav Keynan

Frontiers in Public Health

doi 10.3389/fpubh.2022.1064136

5,328 views
6 citations

Articles

Application of Computational Methods in Understanding Mutations in Mycobacterium tuberculosis Drug Resistance

Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?

Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field

Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis

Trends and impact of government prevention policies on pulmonary tuberculosis notification and mortality in Ningbo, China (2004–2021)

Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies

Relapse or Re-Infection, the Situation of Recurrent Tuberculosis in Eastern China

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis

Effect of population aging on pulmonary tuberculosis burden in Zhejiang Province, China: a population-based study

Consolidation of a genomic epidemiological surveillance network for tuberculosis (REVIGET) in northern and northeastern Brazil: a study protocol

Evaluation of the performance of promising host transcriptional biosignatures in predicting TB progression during a 1-year prospective cohort study in Indian household contacts

Introduction of short course treatment for latent tuberculosis infection at a primary care facility for refugees in Winnipeg, Canada: A mixed methods evaluation